Clinical Trials Browser

Interventional × von Hippel-Lindau Disease × Ranibizumab × Clear all

NCT00089765 2017-07-02

Ranibizumab Injections to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome

Phase 1 Completed

von Hippel-Lindau Disease, Macular Edema, Neoplasms